샘플 요청 목록

 카트 문의
시장보고서
상품코드
1783989

세계의 인슐린 주사 보조기구 시장

Insulin Injection Aids
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 280 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

인슐린 주사 보조기구 세계 시장은 2030년까지 3억 3,790만 달러에 달할 전망

2024년에 2억 4,370만 달러로 추정되는 인슐린 주사 보조기구 세계 시장은 2030년에는 3억 3,790만 달러에 달하고, 분석 기간인 2024-2030년 CAGR은 5.6%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 인슐린 바이알 보조기구는 CAGR 4.0%를 기록하며 분석 기간 종료시에는 1억 1,260만 달러에 달할 것으로 예측됩니다. 시린지 보조기구 부문의 성장률은 분석 기간 동안 CAGR 5.7%로 추정됩니다.

미국 시장은 6,640만 달러로 추정, 중국은 CAGR 8.6%로 성장 예측

미국의 인슐린 주사 보조기구 시장은 2024년에 6,640만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간 2024년부터 2030년까지 CAGR 8.6%로 성장하여 2030년에는 예측 시장 규모 6,700만 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 2.8%와 5.4%로 예측됩니다. 유럽에서는 독일이 CAGR 3.6%로 성장할 것으로 예측됩니다.

세계의 인슐린 주사 보조기구 시장 - 주요 동향과 촉진요인 정리

인슐린 주사 보조기구 수요 확대의 원동력은?

인슐린 주사 보조기구 세계 시장은 전 세계 당뇨병 유병률 증가에 힘입어 큰 폭의 성장세를 보이고 있습니다. 국제당뇨병연맹(IDF)에 따르면, 2045년까지 당뇨병 환자 수가 7억 명을 넘어설 것으로 예측되고 있어 효과적인 인슐린 투여 솔루션의 필요성이 높아지고 있습니다. 인슐린 주사 펜, 니들 가이드, 인슐린 주입기, 안전 주사기 등 인슐린 주입 보조기구는 환자의 인슐린 투여의 정확성, 안전성, 편의성을 높이는 데 중요한 역할을 합니다.

시장 확대를 촉진하는 또 다른 중요한 요인은 환자 친화적인 최소침습적 인슐린 투여 방식으로의 전환입니다. 특히 당뇨병 진단을 받은 지 얼마 되지 않은 환자들은 주사바늘에 대한 불안감이나 부적절한 시술로 인해 자가주사에 어려움을 겪는 경우가 많습니다. 인슐린 주사 보조기구는 주사를 보다 편안하게 하고 투약 실수의 위험을 줄여 치료 순응도를 향상시키는 데 도움이 됩니다. 당뇨병 치료의 자가 관리의 확산과 함께 특히 노인 및 소아 환자들 사이에서 사용하기 쉬운 인슐린 투여 보조기구에 대한 수요가 증가하고 있습니다.

기술 발전은 인슐린 주사 보조기구를 어떻게 향상시키고 있는가?

기술 혁신은 인슐린 주사 보조기구 시장을 변화시키고 있으며, 당뇨병 관리를 보다 효율적이고 환자 친화적으로 만들고 있습니다. 가장 주목할 만한 발전 중 하나는 인슐린 용량, 주사 시기, 순응도를 실시간으로 모니터링할 수 있는 스마트 인슐린 펜과 커넥티드 주사 보조기구의 개발입니다. 이 스마트 기기는 모바일 건강 애플리케이션과 동기화되어 환자와 의료진이 인슐린 사용량을 추적하고, 투여 누락을 감지하고, 치료 계획을 최적화할 수 있게 해줍니다. 주요 의료기기 제조업체들은 인슐린 전달 보조 장치에 블루투스 및 IoT(사물인터넷) 기능을 통합하여 데이터 기반 당뇨병 관리를 개선하고 있습니다.

또 다른 큰 혁신은 제트 인젝터와 같은 바늘을 사용하지 않는 주사 기술의 도입입니다. 제트 인젝터는 고압 공기를 이용해 바늘 없이 인슐린을 주입하는 방식입니다. 이러한 시스템은 주사바늘 공포증 해소, 주사부위 불편감 감소, 환자 순응도 향상에 도움을 주고 있습니다. 또한, 자동 주사기나 가이드 주사기는 최소한의 수작업으로 일관되고 통증 없이 인슐린을 투여할 수 있어 인기를 끌고 있습니다. 이러한 보조기구는 대부분 인체공학적 디자인이 특징이며, 특히 노인이나 관절염 환자 등 손이 불편한 사람들에게 유용합니다.

인슐린 주사 보조기구의 사용을 확대하는 새로운 응용 분야는 무엇인가?

전통적인 당뇨병 관리뿐만 아니라 인슐린 주사 보조기구는 새로운 치료 분야와 헬스케어 환경으로 확대되고 있습니다. 새로운 트렌드 중 하나는 정확한 투약과 안전성이 중요한 병원에서 인슐린 전달 보조기구의 사용이 증가하고 있다는 점입니다. 의료 서비스 제공 업체는 사전 충전 된 인슐린 펜과 바늘 안전 장치를 채택하여 투약 실수를 줄이고 의료진의 우발적 인 바늘 찔림 사고를 예방합니다. 일회용 인슐린 주사 보조기구에 대한 수요는 병원, 특히 엄격한 위생 프로토콜이 요구되는 감염 병동에서도 증가하고 있습니다.

또한, 인슐린 주사 보조 장치와 인공 췌장 시스템 및 연속 혈당 모니터링(CGM) 장치와의 통합으로 용도가 확대되고 있습니다. 당뇨병 치료가 자동 인슐린 투여(AID) 솔루션으로 전환됨에 따라 실시간 포도당 모니터링 시스템을 보완하는 고급 주사 보조 기기가 설계되고 있습니다. 이러한 기술 혁신은 혈당 조절을 개선하고 일상적인 당뇨병 관리의 부담을 덜어주는 데 도움이 되고 있습니다. 또한, AI 기반 데이터 분석에 기반한 개인화된 인슐린 투여 알고리즘을 사용하여 인슐린 투여의 정확도를 높이고, 환자 개개인의 필요에 맞는 치료를 실현하고 있습니다.

인슐린 주사 보조기구 시장의 미래를 형성하는 주요 성장 촉진요인은 무엇인가?

인슐린 주사 보조기구 시장의 성장은 당뇨병 유병률 증가, 자가 관리 당뇨병 관리 솔루션 채택률 증가, 인슐린 전달 기술의 지속적인 발전 등 여러 요인에 의해 주도되고 있습니다. 노인들은 제2형 당뇨병의 위험이 높기 때문에 접근성이 좋고 사용하기 쉬운 인슐린 주사 보조기구가 필요하기 때문입니다. 또한, 소아 당뇨병 인구의 증가로 인해 자동 주사기 및 통증 완화 장치와 같은 어린이 친화적인 인슐린 전달 솔루션에 대한 수요가 증가하고 있습니다.

시장 개척을 촉진하는 또 다른 큰 요인은 신흥국에서의 인슐린 전달 장치의 보급 확대입니다. 각국 정부와 의료 기관은 당뇨병 치료 접근성을 개선하기 위해 저렴한 가격의 혁신적인 인슐린 주사 보조기구에 투자하고 있습니다. 또한, 원격의료 및 디지털 헬스 솔루션의 확대도 시장 확대에 일조하고 있으며, 환자들은 가상 당뇨병 관리 플랫폼을 통해 인슐린 투여에 대한 실시간 안내를 받을 수 있게 되었습니다.

또한, 규제 당국의 지원과 상환 정책은 첨단 인슐린 주사 보조기구의 채택을 촉진하고 있습니다. 현재 많은 헬스케어 시스템이 스마트 인슐린 펜, 자동 주사기, 안전 주사기를 대상으로 하고 있어 환자들에게 더욱 친숙하게 다가서고 있습니다. 또한, 지속가능성과 친환경 디자인 트렌드가 시장에 영향을 미치고 있으며, 제조업체들은 의료 폐기물을 줄이기 위해 생분해성 인슐린 펜 부품과 재활용 가능한 주사 보조기구를 개발하고 있습니다.

더 안전하고, 더 스마트하고, 더 편리한 인슐린 전달 솔루션에 대한 수요가 지속적으로 증가함에 따라 인슐린 주사 보조기구 시장은 스마트 기술, 맞춤형 투약, 바늘 없는 인슐린 전달의 혁신이 당뇨병 치료의 미래를 형성함에 따라 확대될 것으로 보입니다.

부문

제품(인슐린 바이알 보조기구, 시린지 보조기구, 인젝터, 아동용 보조기구, 기타), 최종사용(병원, 전문 클리닉, 재택의료 현장, 기타)

조사 대상 기업 사례

  • AmbiMedInc.
  • Apothecary Products
  • Becton, Dickinson and Co.
  • Bigfoot Biomedical
  • BIONIX LLC
  • Buzzy
  • Convatec Inc.
  • Insuflon Catheter
  • Insulet Corporation
  • Insulin Port Devices
  • Medicool
  • Medtronic Plc
  • Omnipod
  • Pain Care Labs
  • Prodigy Diabetes Care, LLC
  • Steady Shot
  • Steady Shot
  • TickleFLEX
  • TickleTec Ltd

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.08.11

Global Insulin Injection Aids Market to Reach US$337.9 Million by 2030

The global market for Insulin Injection Aids estimated at US$243.7 Million in the year 2024, is expected to reach US$337.9 Million by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Insulin Vial Aids, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$112.6 Million by the end of the analysis period. Growth in the Syringe Aids segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$66.4 Million While China is Forecast to Grow at 8.6% CAGR

The Insulin Injection Aids market in the U.S. is estimated at US$66.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$67.0 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global Insulin Injection Aids Market - Key Trends & Drivers Summarized

What Is Driving the Growing Demand for Insulin Injection Aids?

The global insulin injection aids market is experiencing significant growth, driven by the rising prevalence of diabetes worldwide. According to the International Diabetes Federation (IDF), the number of people living with diabetes is projected to surpass 700 million by 2045, highlighting the increasing need for effective insulin administration solutions. Insulin injection aids, including injection pens, needle guides, insulin dosers, and safety syringes, play a crucial role in enhancing the accuracy, safety, and convenience of insulin delivery for patients.

Another key factor fueling market expansion is the shift towards patient-friendly and minimally invasive insulin administration methods. Many individuals, especially those newly diagnosed with diabetes, struggle with self-injection due to needle anxiety or improper technique. Insulin injection aids help improve adherence to treatment by making injections more comfortable and reducing the risk of dosing errors. With the increasing adoption of self-management practices in diabetes care, demand for user-friendly insulin delivery aids is on the rise, particularly among elderly and pediatric patients.

How Are Technological Advancements Enhancing Insulin Injection Aids?

Technological innovations are transforming the insulin injection aids market, making diabetes management more efficient and patient-friendly. One of the most notable advancements is the development of smart insulin pens and connected injection aids, which enable real-time monitoring of insulin dosage, injection timing, and adherence. These smart devices sync with mobile health applications, allowing patients and healthcare providers to track insulin usage, detect missed doses, and optimize treatment plans. Leading medical device manufacturers are incorporating Bluetooth and IoT (Internet of Things) capabilities into insulin delivery aids, improving data-driven diabetes management.

Another major innovation is the introduction of needle-free injection technologies, such as jet injectors, which use high-pressure air to deliver insulin without the need for a needle. These systems help eliminate needle phobia, reduce injection site discomfort, and improve patient compliance. Additionally, auto-injectors and guided injection devices are gaining popularity, as they provide consistent and painless insulin delivery with minimal manual effort. Many of these aids feature ergonomic designs, making them particularly useful for individuals with limited dexterity, such as elderly patients or those with arthritis.

What Are the Emerging Applications Expanding the Use of Insulin Injection Aids?

Beyond traditional diabetes management, insulin injection aids are expanding into new therapeutic areas and healthcare settings. One emerging trend is the increasing use of insulin delivery aids in hospital settings, where precision dosing and safety are critical. Healthcare providers are adopting pre-filled insulin pens and needle safety devices to reduce dosing errors and prevent accidental needlestick injuries among medical staff. The demand for disposable insulin injection aids is also growing in hospitals, particularly in infectious disease wards where strict hygiene protocols are required.

Another expanding application is the integration of insulin injection aids with artificial pancreas systems and continuous glucose monitoring (CGM) devices. As diabetes care moves toward automated insulin delivery (AID) solutions, advanced injection aids are being designed to complement real-time glucose monitoring systems. These innovations help improve glycemic control and reduce the burden of daily diabetes management. Additionally, the use of personalized insulin dosing algorithms, based on AI-driven data analytics, is enhancing the precision of insulin administration, making treatment more tailored to individual patient needs.

What Are the Key Growth Drivers Shaping the Future of the Insulin Injection Aids Market?

The growth in the insulin injection aids market is driven by several factors, including increasing diabetes prevalence, rising adoption of self-care diabetes management solutions, and continuous advancements in insulin delivery technology. One of the primary growth drivers is the aging global population, as older adults are at higher risk for type 2 diabetes and require accessible and easy-to-use insulin injection aids. Additionally, the rising pediatric diabetes population is creating demand for child-friendly insulin delivery solutions, including auto-injectors and painless delivery devices.

Another major factor fueling market expansion is the increasing penetration of insulin delivery devices in developing countries. Governments and healthcare organizations are investing in affordable and innovative insulin injection aids to improve diabetes care accessibility. The expansion of telemedicine and digital health solutions is also playing a role in market growth, as patients can now receive real-time guidance on insulin administration through virtual diabetes management platforms.

Furthermore, regulatory support and reimbursement policies are driving the adoption of advanced insulin injection aids. Many healthcare systems now cover smart insulin pens, auto-injectors, and safety syringes, making them more accessible to patients. Additionally, sustainability and eco-friendly design trends are influencing the market, with manufacturers developing biodegradable insulin pen components and recyclable injection aids to reduce medical waste.

As the demand for safer, smarter, and more convenient insulin delivery solutions continues to grow, the insulin injection aids market is set to expand, with innovations in smart technology, personalized dosing, and needle-free insulin delivery shaping the future of diabetes care.

SCOPE OF STUDY:

The report analyzes the Insulin Injection Aids market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids, Others); End-Use (Hospitals, Specialty Clinics, Home Care Settings, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • AmbiMedInc.
  • Apothecary Products
  • Becton, Dickinson and Co.
  • Bigfoot Biomedical
  • BIONIX LLC
  • Buzzy
  • Convatec Inc.
  • Insuflon Catheter
  • Insulet Corporation
  • Insulin Port Devices
  • Medicool
  • Medtronic Plc
  • Omnipod
  • Pain Care Labs
  • Prodigy Diabetes Care, LLC
  • Steady Shot
  • Steady Shot
  • TickleFLEX
  • TickleTec Ltd

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Insulin Injection Aids - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Diabetes Prevalence Spurs Demand for Insulin Injection Aids
    • Aging Population and Chronic Disease Burden Expand Addressable Market for Insulin Delivery Devices
    • Shift Toward Self-Administration of Insulin Strengthens Business Case for User-Friendly Injection Aids
    • Smart Insulin Pens and Bluetooth-Enabled Injectors Drive Adoption of Connected Diabetes Management Solutions
    • Increased Focus on Patient Compliance and Convenience Accelerates Demand for Ergonomic Injection Aids
    • Integration of AI and Data Analytics in Insulin Delivery Systems Creates Competitive Differentiation
    • Favorable Reimbursement Policies in Developed Markets Propels Growth in Advanced Injection Aids
    • Rising Healthcare Spending in Emerging Economies Unlocks New Growth Opportunities for Insulin Injection Aids
    • Surge in Home Healthcare and Telemedicine Adoption Drives Use of Portable Insulin Injection Devices
    • Technological Innovations in Needle-Free and Pain-Free Delivery Systems Reshape Patient Preferences
    • Rising Penetration of Digital Health Ecosystems Drives Connectivity and Remote Monitoring Features in Insulin Devices
    • Growing Emphasis on Minimally Invasive Devices Enhances Demand for Micro-Needle and Auto-Injector Aids
    • Increase in Type 2 Diabetes Among Pediatric and Adolescent Populations Expands Product Development Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Insulin Injection Aids Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Insulin Injection Aids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Insulin Injection Aids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Insulin Injection Aids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Insulin Vial Aids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Insulin Vial Aids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Insulin Vial Aids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Syringe Aids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Syringe Aids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Syringe Aids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Aids for Kids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Aids for Kids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Aids for Kids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Insulin Injection Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Insulin Injection Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Insulin Injection Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Insulin Injection Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Insulin Injection Aids by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Insulin Injection Aids by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Insulin Injection Aids by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Insulin Injection Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Insulin Injection Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Insulin Injection Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Insulin Injection Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Injection Aids by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Insulin Injection Aids by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Insulin Injection Aids by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Insulin Injection Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Insulin Injection Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Insulin Injection Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Insulin Injection Aids by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Insulin Injection Aids by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Insulin Injection Aids by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Insulin Injection Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Insulin Injection Aids by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Insulin Injection Aids by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Insulin Injection Aids by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Insulin Injection Aids Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Insulin Injection Aids by Product - Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Insulin Injection Aids by Product - Percentage Breakdown of Value Sales for Insulin Vial Aids, Syringe Aids, Injectors, Aids for Kids and Other Products for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Insulin Injection Aids by End-Use - Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Insulin Injection Aids by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Home Care Settings and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제